159 related articles for article (PubMed ID: 2594553)
1. The enhanced potential use of recombinant alpha interferon in the treatment of AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Oncol Nurs Forum; 1989; 16(6 Suppl):5-7. PubMed ID: 2594553
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
3. Interferon and other biologic agents for the treatment of Kaposi's sarcoma.
Krown SE
Hematol Oncol Clin North Am; 1991 Apr; 5(2):311-22. PubMed ID: 1708760
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
5. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
[TBL] [Abstract][Full Text] [Related]
6. AIDS-associated Kaposi's sarcoma.
Kahn JO; Northfelt DW; Miles SA
AIDS Clin Rev; 1992; ():261-80. PubMed ID: 1606060
[TBL] [Abstract][Full Text] [Related]
7. [Recovery of chronic hepatitis B- delta infection by zidovudine and recombinant interferon alpha combination therapy in a patient with Kaposi's sarcoma associated with HIV infection].
Gaudin JL; Causse X; Zoulim F; Chevallier M; Trépo C
Gastroenterol Clin Biol; 1992; 16(5):468-72. PubMed ID: 1526401
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
11. Treatments of AIDS-related Kaposi's sarcoma.
Aversa SM; Cattelan AM; Salvagno L; Crivellari G; Banna G; Trevenzoli M; Chiarion-Sileni V; Monfardini S
Crit Rev Oncol Hematol; 2005 Mar; 53(3):253-65. PubMed ID: 15718150
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
15. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
16. The role of alpha interferon in the biotherapy of hematologic malignancies and AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Oncol Nurs Forum; 1988; 15(6 Suppl):7-12. PubMed ID: 3060868
[No Abstract] [Full Text] [Related]
17. Kaposi's sarcoma in the acquired immunodeficiency syndrome.
Mitsuyasu RT
Infect Dis Clin North Am; 1988 Jun; 2(2):511-23. PubMed ID: 3060533
[TBL] [Abstract][Full Text] [Related]
18. Acquired immunodeficiency syndrome-related Kaposi's sarcoma: clinical features, staging, and treatment.
Dezube BJ
Semin Oncol; 2000 Aug; 27(4):424-30. PubMed ID: 10950369
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
Samaniego F; Markham PD; Gallo RC; Ensoli B
J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237
[TBL] [Abstract][Full Text] [Related]
20. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
